Status:
COMPLETED
Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With Viramune
Lead Sponsor:
Boehringer Ingelheim
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Brief Summary
The question that prompted this study is the extent to which results from clinical trials can be translated into everyday practice (external validity). An observation period of about 10 years extends ...
Detailed Description
Study Design: observational
Eligibility Criteria
Inclusion
- Inclusion criteria The inclusion criteria for treatment with Viramune plus other antiretroviral combination drugs are to be based on the current Information for Healthcare Professionals/SPC (R08-0843)
- Exclusion criteria The exclusion criteria for treatment with Viramune plus other antiretroviral combination drugs are to be based on the current Information for Healthcare Professionals/SPC (R08-0843).
Exclusion
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00979420
Start Date
August 1 2009
Last Update
June 30 2014
Active Locations (60)
Enter a location and click search to find clinical trials sorted by distance.
1
Boehringer Ingelheim Investigational Site 1
Aachen, Germany
2
Boehringer Ingelheim Investigational Site 10
Berlin, Germany
3
Boehringer Ingelheim Investigational Site 11
Berlin, Germany
4
Boehringer Ingelheim Investigational Site 12
Berlin, Germany